Endogenous calcification inhibitors in the prevention of vascular calcification: a consensus statement from the COST action EuroSoftCalcNet

The physicochemical deposition of calcium-phosphate in the arterial wall is prevented by calcification inhibitors. Studies in cohorts of patients with rare genetic diseases have shed light on the consequences of loss-of-function mutations for different calcification inhibitors, and genetic targeting...

Full description

Bibliographic Details
Main Author: Bäck, Magnus (author)
Other Authors: Aranyi, Tamas (author), Cancela, M. Leonor (author), Carracedo, Miguel (author), Conceição, Natércia (author), Leftheriotis, Georges (author), Macrae, Vicky (author), Martin, Ludovic (author), Nitschke, Yvonne (author), Pasch, Andreas (author), Quaglino, Daniela (author), Rutsch, Frank (author), Shanahan, Catherine (author), Sorribas, Victor (author), Szeri, Flora (author), Valdivielso, Pedro (author), Vanakker, Olivier (author), Kempf, Hervé (author)
Format: article
Language:eng
Published: 2019
Subjects:
Arterial calcification
Pyrophosphate
Gla proteins
Klotho
Osteoprotegerin
Osteopontin
Fetuin
Online Access:http://hdl.handle.net/10400.1/12534
Country:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/12534

Internet

http://hdl.handle.net/10400.1/12534

Similar Items